View : 18 Download: 0
Expression of Smad 2 and 3 on the lesions of leprosy
- Expression of Smad 2 and 3 on the lesions of leprosy
- Lee H.S.; Lee J.R.; Choi G.S.; Shin J.H.; Choi H.Y.
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- Korean Journal of Dermatology
- Korean Journal of Dermatology vol. 44, no. 3, pp. 304 - 308
- SCOPUS; KCI
- Document Type
- Background: Leprosy is an infections disease with two polar forms, tuberculoid leprosy (TT) and lepromatous leprosy (LL), that are characterized by strong cell-mediated immunity (CMI) and CMI anergy, respectively. Transforming growth factor-β (TGF-β) is a family of growth factors involved in essential physiological processes, including development, differentiation, tissue repair, cell growth control and inflammation. Cellular signaling by TGF-β family members is initiated by the assembly of specific cell surface receptors that activate transcription factors of the Smad family. Deregulation of the TGF-β-Smad signaling pathway has been implicated in developmental disorders and several human diseases. Recently, ELISA & immunohistochemistry revealed high expression of TGF-β isoforms in LL. Objective: The purpose of this study was to investigate TGF-β-Smad signaling in various forms of leprosy. Methods: We investigated the involvement of TGF-β by immunohistochemical staining for Smad 2 and 3 in skin biopsies from six patients of BL and four patients of TT. Results: The inflammatory cells, keratinocytes and fibroblasts in BL showed strong positivity for both Smad 2 and 3, whereas those in TT showed little positivity. Conclusion: The high expression of Smad 2/3 in BL could represent high expression of TGF-β, which possibly contributes to local CMI anergy and other clinical characteristic features of leprosy.
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.